|
Index of reports
> Cases with Pancytopenia ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Viread (Tenofovir Disoproxil) where reactions include pancytopenia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Viread side effects in 45 year old female
Reported by a physician from France on 2011-12-13
Patient: 45 year old female
Reactions: Weight Decreased, Drug Resistance, Acute Generalised Exanthematous Pustulosis, Generalised Erythema, Castleman's Disease, Pancytopenia, Anaphylactic Shock, Asthenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Norvir
Indication: HIV Infection
Start date: 2010-05-28
End date: 2010-06-01
Sustiva
Administration route: Oral
Prezista
Start date: 2010-05-28
End date: 2010-06-01
Nevirapine
Isentress
Administration route: Oral
Indication: HIV Infection
Start date: 2010-06-25
End date: 2010-06-01
Isentress
Administration route: Oral
Start date: 2010-08-17
End date: 2010-01-01
Viread
Start date: 2010-05-28
End date: 2010-06-01
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2010-08-19
Videx
Administration route: Oral
Indication: HIV Infection
Start date: 2010-06-25
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2010-06-25
End date: 2010-06-01
Viread
Start date: 2010-08-11
End date: 2010-08-11
Other drugs received by patient: Piascledine
Possible Viread side effects in 45 year old female
Reported by a physician from France on 2011-11-23
Patient: 45 year old female
Reactions: Weight Decreased, Drug Resistance, Generalised Erythema, Acute Generalised Exanthematous Pustulosis, Castleman's Disease, Anaphylactic Shock, Pancytopenia, Asthenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Norvir
Indication: HIV Infection
Start date: 2010-05-28
End date: 2010-06-01
Viread
Start date: 2010-08-11
End date: 2010-08-11
Isentress
Administration route: Oral
Indication: HIV Infection
Start date: 2010-06-25
End date: 2010-06-01
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2010-06-25
End date: 2010-06-01
Prezista
Start date: 2010-05-28
End date: 2010-06-01
Isentress
Administration route: Oral
Start date: 2010-08-17
End date: 2010-01-01
Sustiva
Administration route: Oral
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2010-08-19
Videx
Administration route: Oral
Indication: HIV Infection
Start date: 2010-06-25
Viread
Start date: 2010-05-28
End date: 2010-06-01
Nevirapine
Other drugs received by patient: Piascledine
Possible Viread side effects in 45 year old female
Reported by a consumer/non-health professional from France on 2011-11-20
Patient: 45 year old female
Reactions: Weight Decreased, Acute Generalised Exanthematous Pustulosis, Drug Resistance, Castleman's Disease, Pancytopenia, Asthenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Reyataz
Dosage: reintroduced on 19aug10
Administration route: Oral
Indication: HIV Infection
Start date: 2010-08-19
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2010-06-25
Prezista
Isentress
Dosage: reintroduced 17aug10,isentress 400mg film-coated tablet.
Administration route: Oral
Indication: HIV Infection
Start date: 2010-06-25
Efavirenz
Viread
Start date: 2010-08-11
Videx
Administration route: Oral
Indication: HIV Infection
Start date: 2010-06-25
Norvir
Indication: HIV Infection
Start date: 2010-05-28
Other drugs received by patient: Piascledine
|
